Connor, Clark & Lunn Investment Management (CC&L)’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-129,093
Closed -$12.8M 1170
2019
Q3
$12.8M Sell
129,093
-550
-0.4% -$52.3K 0.09% 156
2019
Q2
$12M Buy
129,643
+18,175
+16% +$1.73M 0.08% 174
2019
Q1
$10.5M Buy
111,468
+74,500
+202% +$6.52M 0.07% 184
2018
Q4
$2.37M Buy
36,968
+4,850
+15% +$358K 0.02% 386
2018
Q3
$2.87M Sell
32,118
-235,500
-88% -$20.8M 0.02% 384
2018
Q2
$21.3M Sell
267,618
-171,983
-39% -$14.3M 0.12% 131
2018
Q1
$39.2M Buy
439,601
+107,608
+32% +$10.3M 0.24% 82
2017
Q4
$34.6M Buy
331,993
+174,800
+111% +$19.7M 0.2% 90
2017
Q3
$22.9M Buy
157,193
+105,750
+206% +$14.4M 0.14% 119
2017
Q2
$6.68M Buy
51,443
+17,025
+49% +$2.09M 0.04% 236
2017
Q1
$4.28M Sell
34,418
-1,200
-3% -$144K 0.03% 274
2016
Q4
$4.12M Buy
35,618
+4,300
+14% +$479K 0.03% 274
2016
Q3
$3.27M Buy
31,318
+118
+0.4% +$12.8K 0.02% 299
2016
Q2
$3.08M Sell
31,200
-10,625
-25% -$1.1M 0.02% 300
2016
Q1
$4.19M Sell
41,825
-96,825
-70% -$9.97M 0.03% 243
2015
Q4
$16.6M Sell
138,650
-15,625
-10% -$1.81M 0.14% 102
2015
Q3
$16.7M Buy
+154,275
New +$19.1M 0.14% 95
2014
Q3
Sell
-16,800
Closed -$1.54M 629
2014
Q2
$1.54M Buy
+16,800
New +$1.28M 0.01% 274
2014
Q1
Sell
-126,368
Closed -$11.3M 851
2013
Q4
$11.3M Buy
126,368
+105,068
+493% +$8.31M 0.09% 96
2013
Q3
$1.69M Buy
21,300
+10,100
+90% +$708K 0.02% 218
2013
Q2
$691K Buy
+11,200
New +$674K 0.01% 314

Other funds holding CELG

Connor, Clark & Lunn Investment Management (CC&L)'s CELG Position: Q4 2019 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 129,093 shares — an estimated $12.8M sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in CELG in Q2 2013 and held it in 21 quarters. The position peaked at $39.2M in Q1 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 129,093 Celgene Corp shares in Q4 2019, an estimated $12.8M.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Celgene Corp in Q2 2013 and held it in 21 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Celgene Corp position peaked at $39.2M in Q1 2018.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q4 2019, filed 12 Feb 2020.